Related Experiment Video
Updated: Aug 9, 2026

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
Published on: June 17, 2015
A study of package inserts of potentially toxic drugs
Abstract:
Information contained in the package inserts of drugs chosen as potential causes of blood dyscrasia, renal toxicity, hepatotoxicity, and cardiac toxicity has been studied. Chloramphenicol and pyrazolones were chosen as representatives of drugs that could produce blood dyscrasia, aminoglycosides and cephaloridine as potential nephrotoxic agents, isoniazid and monoamine oxidase inhibitors as possible hepatotoxic drugs, and tricyclic antidepressants and digitalis as drugs of recognized cardiac toxicity. Adverse effects were clearly described in only 27.8% of the package inserts, whereas 40.3% did not mention them, and 15.7% specifically stated that the product was devoid of adverse effects. Information about the type of toxicity that led to the selection of drugs included in this study was uncommon in most cases.
More Related Videos
11:38High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
Published on: May 10, 2016
14:34A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
Published on: April 3, 2026
Related Concept Videos
Drug Regulation
Dosage Regimens: Designs and Approaches
Drug Toxicity: Overview
Drug Toxicity: Risk factors
Drug toxicity: Drug–Drug Interaction
Pharmaceutical Poisoning: Potential Scenarios